CLASSIC-I study the efficacy of adalimumab
- PMID: 16697761
- DOI: 10.1053/j.gastro.2006.03.050
CLASSIC-I study the efficacy of adalimumab
Comment on
-
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.Gastroenterology. 2006 Feb;130(2):323-33; quiz 591. doi: 10.1053/j.gastro.2005.11.030. Gastroenterology. 2006. PMID: 16472588 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical